5 issues to know Friday


FDA weighing approval of a 3rd COVID-19 vaccine

A proposed new COVID-19 vaccine from Johnson & Johnson is anticipated to get a thumbs-up Friday from a Meals and Drug Administration (FDA) advisory committee. If the FDA formally grants authorization as anticipated inside the subsequent few days the U.S. may have three authorized vaccines. Like the opposite two, from Moderna and Pfizer-BioNTech, the Johnson & Johnson vaccine underwent a big scientific trial displaying its security and effectiveness. The J&J vaccine differs from the 2 already approved, as a result of just one shot is advisable, as an alternative of two. In the meantime, beginning Friday, the COVID-19 vaccine might be accessible in choose CVS shops in 17 states. The pharmacy chain introduced Wednesday that it might be increasing its vaccination rollout to pharmacies in six states: Alabama, Arizona, Florida, Louisiana, Ohio and Pennsylvania. 

Desire to pay attention? Try the 5 issues podcast



Supply hyperlink